Alberta Confirms Country’s Second Blood Clot After AstraZeneca Vaccine Dose

A vial of the AstraZeneca COVID-19 vaccine is seen with injection supplies at a clinic in Winnipeg, on March 19, 2021. The Canadian Press/John Woods

Alberta has confirmed a rare blood clot case in a patient who received the Oxford-AstraZeneca vaccine, the province’s chief medical officer of health announced on Saturday.

Dr. Deena Hinshaw said the male patient, who is in his 60s and recovering, marks the second Canadian case of the blood clot disorder known as vaccine-induced immune thrombotic thrombocytopenia, or VITT.